(LU) Lufax Holding - Ratings and Ratios

Exchange: NYSE • Country: China • Currency: USD • Type: Common Stock • ISIN: US54975P1021

LU: Loans, Consumer Finance, Wealth Management, Asset Management, Trust Products

Lufax Holding Ltd is a prominent financial services institution in China, primarily catering to the needs of small and micro businesses. The company's loan products are diverse, encompassing both general unsecured loans and secured loans, which provide businesses with the necessary capital to expand their operations or manage cash flow. Additionally, Lufax offers consumer finance loans, enabling individuals to access credit for various personal needs. By providing these loan products, Lufax plays a crucial role in facilitating economic growth and development in China.

Beyond its lending capabilities, Lufax Holding Ltd also offers a range of wealth management products, designed to help individuals and businesses manage their assets effectively. These products include asset management plans, which provide a structured approach to investing, as well as mutual fund products, private investment fund products, and trust products. This comprehensive suite of wealth management solutions enables clients to diversify their investments, mitigate risk, and achieve their long-term financial objectives. With its headquarters in Shanghai, China, Lufax is well-positioned to serve the country's growing middle class and increasingly sophisticated investor base.

Founded in 2005, Lufax Holding Ltd has established itself as a leading player in China's financial services sector. The company's website, https://www.lufaxholding.com, provides investors and clients with access to a wealth of information about its products and services. Listed on the New York Stock Exchange (NYSE) under the ticker symbol LU, Lufax's common stock is traded under the ISIN code US54975P1021. As a member of the consumer finance sub-industry, Lufax is classified under the GICS Sub Industry: Consumer Finance, reflecting its focus on providing financial solutions to individuals and small businesses.

Additional Sources for LU Stock

LU Stock Overview

Market Cap in USD 2,098m
Sector Financial Services
Industry Credit Services
GiC Sub-Industry Consumer Finance
IPO / Inception 2020-10-30

LU Stock Ratings

Growth 5y -68.5%
Fundamental 16.3%
Dividend 61.9%
Rel. Strength Industry 415
Analysts 3.56/5
Fair Price Momentum 3.04 USD
Fair Price DCF 243.55 USD

LU Dividends

Dividend Yield 12m 57.35%
Yield on Cost 5y 8.25%
Annual Growth 5y 5.86%
Payout Consistency 79.1%

LU Growth Ratios

Growth Correlation 3m -46.5%
Growth Correlation 12m 74.9%
Growth Correlation 5y -89.7%
CAGR 5y -36.81%
CAGR/Mean DD 5y -0.49
Sharpe Ratio 12m 1.55
Alpha 151.71
Beta 1.09
Volatility 63.85%
Current Volume 4604.6k
Average Volume 20d 2369.8k
What is the price of LU stocks?
As of January 23, 2025, the stock is trading at USD 2.72 with a total of 4,604,600 shares traded.
Over the past week, the price has changed by +16.74%, over one month by +11.93%, over three months by -10.23% and over the past year by +180.09%.
Is Lufax Holding a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Lufax Holding is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.30 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LU as of January 2025 is 3.04. This means that LU is currently undervalued and has a potential upside of +11.76% (Margin of Safety).
Is LU a buy, sell or hold?
Lufax Holding has received a consensus analysts rating of 3.56. Therefor, it is recommend to hold LU.
  • Strong Buy: 3
  • Buy: 0
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0
What are the forecast for LU stock price target?
According to ValueRays Forecast Model, LU Lufax Holding will be worth about 3.3 in January 2026. The stock is currently trading at 2.72. This means that the stock has a potential upside of +20.59%.
Issuer Forecast Upside
Wallstreet Target Price 3 8.8%
Analysts Target Price 3 8.8%
ValueRay Target Price 3.3 20.6%